- Coordinator
- Panepistimio Ioanninon, Greece
- Runs
- 1 June 2025 to 31 May 2029
- Status
- Running
- EU funding
- €6.0m
- Total cost
- €6.0m
- Partners
- 16 organisations in 10 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101213323
What the project is doing
In the project's own words, from its summary on CORDIS.
MAYA addresses the third intervention outlined in the call by developing, testing, and scaling up innovative, holistic approaches and tools for managing late effects of cancer treatment in AYA cancer (of any type) survivors. MAYA aims to empower Adolescents and Young Adults (AYA) cancer survivors to manage their cardiovascular (CV) health through digital tools that address cardiotoxic-related late effects of cancer treatment.
The project envisions using the iCARE health hub, which integrates a smart mirror and an AI-powered conversational agent, to deliver personalised care and continuous monitoring. The ultimate goal is to improve cardiovascular outcomes and overall quality of life for AYA survivors by managing modifiable risk factors such as hypertension, diabetes, and obesity, with an expected reduction in the risk of major cardiac events by 30-40%.MAYA will achieve these objectives through advanced AI-driven data analysis, real-time biomarker tracking, and participatory research methods including social innovation, multistakeholder engagement, and Living Labs.
The project will test these solutions in real-world settings through clinical studies involving AYA cancer survivors in multiple European countries. By focusing on personalised interventions and continuous health monitoring, MAYA directly aligns with the objectives of the Horizon Europe work programme, particularly the Cancer Mission's goals of improving long-term health outcomes and quality of life for cancer survivors.
Additionally, the project contributes to the work programme’s emphasis on innovation in healthcare and equity across diverse healthcare systems. This action is part of the Cancer Mission cluster of projects on “Quality of life (AYA).
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Panepistimio Ioanninon | Ioannina | Greece | Coordinator |
| Charite - Universitaetsmedizin Berlin | Berlin | Germany | Participant |
| Idryma Technologias Kai Erevnas | Irakleio | Greece | Participant |
| Asociacion Empresarial De Investigacion Centro Tecnologico Del Mueble Y La Madera De La Region De Murcia | Yecla | Spain | Participant |
| Duriglass S.l | Aldaya | Spain | Participant |
| Universidad De Castilla - La Mancha | Ciudad Real | Spain | Participant |
| Nhg Finland Oy | Helsinki | Finland | Participant |
| Sylva ry | Helsinki | Finland | Participant |
| Echalliance Company Limited by Guarantee | Dublin | Ireland | Participant |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Participant |
| Istituto Romagnolo per Lo Studio Dei Tumori Dino Amadori - Irst SRL | Meldola | Italy | Participant |
| Gdanski Uniwersytet Medyczny | Gdansk | Poland | Participant |
| Instituto Portugues De Oncologia De Coimbra Francisco Gentil, E.p.e. | Coimbra | Portugal | Participant |
| Shine 2europe Lda | Coimbra | Portugal | Participant |
| Asociatia Centrul Pentru Inovatie in Medicina | Bucharest | Romania | Participant |
| Robert Gordon University | Aberdeen | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI